Two Patients’ Health Deteriorated After Injection In Halat Hospital, Kanpur

Kanpur : The condition of two patients deteriorated after metronidazole injection at Halat Hospital of Kanpur Medical College on Tuesday. After this, the Chief Superintendent of the hospital banned this medicine. He said that all the medicines received in the hospital have been recalled from the wards and all recalled Bottles will be sealed and sent for investigation.

Chief Superintendent of the hospital, RK Singh, said that all the stock sent to the wards, apart from the stock kept in the store has also been sealed. A committee has been formed to investigate the reality. There will be five members in this committee who will have all the information about the medicine. He said that now only Metrogyl injections coming from Medical Supply Corporation will be given to the urgent patients admitted in the hospital.

RK Singh said that the injection had worsened the condition of the patients. That medicine is from Ahmedabad company Otsuk. There is a complete ban on purchasing this medicine. Now this injection will never be bought in Halat in future also. Earlier, the condition of many patients had deteriorated due to the use of the same injection in the maternal and child ward.

RK Singh said that these injections were sent to 17 wards, out of which the condition of two patients admitted in Ward 3 has deteriorated. There have been no side effects to the patients in any of the other wards, but despite this, this medicine has been recalled from all the wards.

Related Posts

  • Pharma
  • July 22, 2025
  • 143 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

  • Pharma
  • July 16, 2025
  • 567 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug